Press Releases

ST. LOUIS, Oct. 28, 2019 /PRNewswire/ -- Oakrum Pharma, LLC ("Oakrum"),  in collaboration with SunGen Pharma, LLC ("SunGen"), announced today the U.S. launch and commercial shipment of a generic version of Medrol® (Methylprednisolone) in 4 mg tablets. It is anticipated that the product will serve the retail market with annual sales in the U.S. exceed

KIBBUTZ GALED, Israel, Oct. 28, 2019 /PRNewswire/ -- Biogal Galed Labs, a global leader of veterinary diagnostic solutions, has announced the commercialization of the new RoboComb, an automated development robot

MIAMI, Oct. 28, 2019 /PRNewswire/ -- VITAS® Healthcare, the nation's leading provider of end-of-life care, has named Rory Farrand as director of VITAS® Palliative Care.

ARLINGTON, Va., Oct. 28, 2019 /PRNewswire/ -- In conjunction with a session at the Academy of Nutrition and Dietetics Food & Nutrition Conference & Expo (FNCE), the American Diabetes Association (ADA) is releasing a new resource to help people living with diabetes answer one of the most common and challenging questions: 'What can I eat?' The new resource is free

BOSTON, Oct. 28, 2019 /PRNewswire/ -- Primary care is the most common touchpoint in medicine, and yet increasing patient demand, expanding provider responsibilities and evolving payment models threaten the sustainability of this essential element of the healthcare system. New technological approaches combined with the drive to move care to lower cost settings are en

HOUSTON and VANCOUVER, Oct. 28, 2019 /PRNewswire/ - ESSA Pharma Inc. (Nasdaq: EPIX; TSX-V: EPI), a pharmaceutical company focused on developing novel therapies for the treatment of prostate cancer, today in Boston will present new preclinical data on ESSA's lead Investigational New Drug ("IND") candidate a

SUNNYVALE, Calif., Oct. 28, 2019 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) – Thailand's Lopburi Cancer Hospital, a center of excellence for cancer treatment, is the first in the Asia-Pacific region to clinically use the combination of RaySearch's treatment planning system RayStation&re

MALVERN, Pa., Oct. 28, 2019 /PRNewswire/ -- Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on designing, developing and marketing products that improve the quality of life for patients who suffer from psychiatric disorders, today announced a partnership with Success TMS, a healthcare provider specializing in transcrani

DUBLIN, Oct. 28, 2019 /PRNewswire/ -- Endo International plc (NASDAQ: ENDP) announced that Endo Aesthetics launched a "Redefining Scientific Artistry" campaign at the Annual Meeting of the American Society for Dermatologic Surgery (ASDS) held in Chicago, IL from October 24 - 27, 2019. The campaign launched wi

NEW HAVEN, Conn., Oct. 28, 2019 /PRNewswire/ -- Biohaven Pharmaceutical Holding Company Ltd. (NYSE: BHVN), a clinical-stage biopharmaceutical company with a portfolio of innovative, late-stage product candidates targeting neurologic and neuropsychiatric diseases, today announced that it has completed enrollment in its pivotal Phase 3 clinical trial assessing th